Cytokines continue to be one of the hottest thing in #immunotherapy
— Andy Biotech (@AndyBiotech) January 10, 2019
Here comes an interesting protein engineering work of a more stable version of IL-2/15 with reduced toxicityhttps://t.co/Q4vEwGy1quhttps://t.co/7lagoFJAxl
and a new startup @neoleukin -> watch out $NKTR $THOR pic.twitter.com/xgSGNhrMD8
1) An important paper on ME/CFS was published today (Valdez et al. 2019). The authors looked at a large medical insurance database of 50 million people. This gave insight into enormous data about ME/CFS.
— Michiel Tack (@MTackCVS) January 8, 2019
The paper is open access and can be read here: https://t.co/oXUYqtD4cJ
A sac of key references, budding with insight, nothing basic about it. Lysosomes in disease biology, a review by Lawrence and Zoncu. https://t.co/LKHfJclkQa
— Jay Bradner, M.D. (@jaybradner) January 7, 2019
Artificial sweeteners have been implicated for all sorts of things, including weight gain, #obesity weight loss & #cancer. Now a systematic analysis of 56 studies (largest to date) suggests mostly no impact (+ or -)https://t.co/EatLqefST0 @bmj_latest #OA@meerpohl @Cochrane_DE pic.twitter.com/ooCWYZ4vRi
— Eric Topol (@EricTopol) January 2, 2019
Our new Illustrated Glossary includes a wide range of simple, illustrated definitions of complex key terms. Explore this new feature: https://t.co/6Ixo6ozq1Z pic.twitter.com/ICE92HbYED
— NEJM (@NEJM) December 29, 2018
With 2018 coming to a close, here are my top ten choices for #PancreaticCancer papers published this year. I tried to cover the full spectrum with a “bias” towards clinic ready/translational studies. Please feel free to add your own. Obviously this list deserves to be longer.
— Anirban Maitra (@Aiims1742) December 30, 2018
Big splash for #CRISPR/Cas9 editing from the @SontheimerLab: Compact, high fidelity Cas9, that edits genomes with little or no off-targeting □https://t.co/05sUSetYUf
— RNA Therapeutics (@UMassMedRTI) December 21, 2018
Excellent collection of #OpenAccess articles on gene therapy in @NatureOutlook https://t.co/pagLgFF5XH#SickleCellhttps://t.co/K19ZKk9o0M#Epilepsyhttps://t.co/h2akwJ9ypU
— Andy Biotech (@AndyBiotech) December 14, 2018
This beautiful work on EB is still my favorite GT storyhttps://t.co/JhKt2jb6dvhttps://t.co/jI3uf22m2n pic.twitter.com/G7nG8g6hKd
New Review by Jake O’Donnell, Michele Teng & Mark Smyth now live online: 'Cancer immunoediting and resistance to T cell-based immunotherapy' - https://t.co/ppr8ZfK8Kz pic.twitter.com/cZEM5hKz1h
— NatureRevClinOncol (@NatRevClinOncol) December 6, 2018
After the BiTEs, the CiTEs (logically the DiTES come next)
— Biotech Radar (@BiotechRadar) December 6, 2018
Blood Commentaryhttps://t.co/RUXNQHztBB
Article
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemiahttps://t.co/PNcc02COQV pic.twitter.com/aXcDffGn4U
Wow, this CNS drug delivery work using Toxoplasma is super cool!
— Andy Biotech (@AndyBiotech) December 4, 2018
Engineering Brain Parasites for Intracellular Delivery of Therapeutic Proteinshttps://t.co/FAryMiJo27
Congrats @shaharbrr @OdedRechavi and look fwd to see data in animal model next!https://t.co/2YTEBWxzs8 pic.twitter.com/3vPbO1VSOt
Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunityhttps://t.co/QeOWLeA7lp
— Elisabeth Bik (@MicrobiomDigest) November 21, 2018
REDUCE-IT trial: when added to statins in its w/ CVD (or T2D+1RF), Rx with 4g purified EPA (Vascepa) (compared to mineral oil placebo) lowered risk CVD events □□
— Sek Kathiresan MD (@skathire) November 10, 2018
Vascepa worked but full results expose that we don’t know why
A few thoughtshttps://t.co/Tgmd14AXqo pic.twitter.com/lxMeP9uMmp
RSS Feed
